This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Raxtozinameran
- DrugBank Accession Number
- DB18228
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Other vaccines - Synonyms
- Comirnaty Omicron XBB.1.5
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Comirnaty Injection, suspension 0.043 mg/0.432mL Intramuscular Pfizer Laboratories Div Pfizer Inc 2023-09-11 2024-06-30 US 
Comirnaty Injection, suspension 0.042 mg/0.418mL Intramuscular Pfizer Laboratories Div Pfizer Inc 2023-10-31 Not applicable US Comirnaty Injection, suspension 0.048 mg/0.48mL Intramuscular Pfizer Laboratories Div Pfizer Inc 2023-09-11 Not applicable US Comirnaty Omicron XbB.1.5 Suspension 10 mcg / 0.3 mL Intramuscular Biontech Manufacturing Gmbh 2023-10-23 Not applicable Canada 
Comirnaty Omicron XbB.1.5 Suspension 10 mcg / 0.2 mL Intramuscular Biontech Manufacturing Gmbh Not applicable Not applicable Canada
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Terminated Prevention Cancer / Coronavirus Disease 2019 (COVID‑19) 1 Not Available Active Not Recruiting Not Available Anesthetics Adverse Reaction / Coronavirus Disease 2019 (COVID‑19) / Safety / Vaccines 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension Intramuscular 0.042 mg/0.418mL Injection, suspension Intramuscular 0.043 mg/0.432mL Injection, suspension Intramuscular 0.048 mg/0.48mL Suspension Intramuscular 10.00 mcg Suspension Intramuscular 10 mcg / 0.2 mL Suspension Intramuscular 10 mcg / 0.3 mL Suspension Intramuscular 3 mcg / 0.2 mL Suspension Intramuscular 30 mcg / 0.3 mL Injection, suspension Intramuscular 0.0158 mg/0.48mL Injection, suspension Intramuscular 0.0158 mg/1.58mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 14, 2023 16:26 / Updated at September 15, 2023 10:39